VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CMECME Group Inc.
$311.56$112.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
CME logo

CME Group Inc.

CME
NASDAQ · Exchanges & Financial Data
$311.56
At close - Nov 17, 4:00 PM EST - USD
Market Cap$112.03B
P/E25.4x
52W High$329.16
Volume1.73M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Fee Dominance Offsets Structural Balance Sheet Drift

CME's earnings engine remains transaction fees, with non-interest income exceeding 100% of total revenue through 2024-2025 and an efficiency ratio ranging 4.3%-29.0% that appears to gap exchange peers such as ICE at 38.7% and CBOE at 32.1%; 2026Q3 delivered $2.89 diluted EPS on $1.7B of revenue, a 16.1% year-over-year…

GrowthExpanding
ProfitabilityStrong
ValuationExpensive
TechnicalsStrong
Explore valuation models
MARKET ACTION

CME price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

11/12 Beats

EPS beat 11 of last 12 quarters

02

Valuation risk

+20% Peers

P/E is 20% above peer median

03

Market leadership

RS 74 · Avg

Average momentum (RS Rating: 74)

04

Strong Uptrend

Strong Trend

Price > 20DMA > 50DMA > 200DMA

Next CatalystEstimated earnings · Jan 21
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Transaction fees remain the sole earnings driver with fee income above 100% of revenue through 2025 and reaching $1.9B in 2026Q1 before reclassifying to $319.2M in 2026Q3, while the efficiency ratio of 4.3%-29.0% signals substantial operating leverage but structural revenue volatility.

Analyst Consensus+3.2% target
Hold(37 analysts)
15 Buy18 Hold4 Sell

The Bull Case

Upside Catalysts

World‑Leading Derivatives Marketplace

CME Group operates the world’s leading derivatives marketplace, providing critical infrastructure for futures and options across interest rates, equities, currencies, commodities, and cryptocurrencies. Its network effects mean that liquidity attracts more traders, which in turn strengthens its dominant position.

Consistent Revenue Growth 2025

CME posted a 6.32% revenue increase in 2025, reaching $6.51 billion. The growth is driven by strong trading volumes, especially in the Market Data segment, and has resulted in record operating income and Adjusted EPS.

Volatility Drives Trading Activity

Geopolitical uncertainty, interest‑rate swings, and economic shifts increase market volatility, which directly benefits CME by boosting trading activity and the demand for hedging instruments.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
CME+19.26%
S&P 500 (^GSPC)+7.21%
1-Year Return
CME+15.67%
S&P 500 (^GSPC)+10.03%
3-Year Return
CME+60.88%
S&P 500 (^GSPC)+57.92%
5-Year Return
CME+58.69%
S&P 500 (^GSPC)+52.59%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y High
25.4x
Forward P/EExpansion
25.1x
EV/EBITDA80th %ile
22.6x
FCF YieldCash Flow
3.9%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
25.4x
24.0x
80th· High
EV/EBITDA
22.6x
20.1x
80th· High
Price/FCF
25.9x
23.2x
80th· High
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$223.43-28.3%
Base (Fair)$264.13-16.9%
Bull$278.26-10.7%
$223.43 Bear$264.13 Base$278.26 Bull
Current Market Price: $311.56
Trades at a 18.0% premium to Base DCF ($264.13)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$6.39B+7.1% YoY
Net income FY25
$4.04B+14.7% YoY
Free cash flow FY25
$4.19B+16.6% YoY
Operating margin FY25
66.2%+0.3 pts YoY
ROIC (FY25)10.2%
Avg ROIC 5Y8.5%
ROE (TTM)16.2%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate11/12 (92%)
Revenue Beat Rate9/12 (75%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Oct 21, 2026
$3.02+1.0%
vs $2.99
$1.7B+1.3%
vs $1.7B
Q3 2026
Jul 22, 2026
$2.99+2.7%
vs $2.91
$1.7B+1.4%
vs $1.7B
Q2 2026
Apr 22, 2026
$3.36+0.6%
vs $3.34
$1.9B+0.3%
vs $1.9B
Q1 2026
Feb 4, 2026
$2.77+0.7%
vs $2.75
$1.6B+0.1%
vs $1.6B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
The Motley Fool·1d ago
CME vs. Toast: Which Financial Stock Is a Better Buy for 2027?

CME Group maintains a dominant position in global derivatives with exceptionally high net margin levels. Toast is rapidly expanding its restaurant technology ecosystem and has recently achieved consistent profitability.

Defense World·1d ago
22,749 CME Group Inc. $CME Shares Sold by Banco Santander S.A.

Banco Santander S.A. cut its stake in CME Group Inc. (NASDAQ: CME) by 19.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 96,382 shares of the financial services provider's stock after selling 22,749 shares during the period. Banco

247 Wallst·2d ago
"I Never Once Said Cardano Is Finished." Cardano’s Founder Clashes With Its Foundation As ADA Is Down Over 40% Since October

Charles Hoskinson wants to know who owns the shares in a spinoff the Cardano Foundation built, and the Foundation has not answered. The unresolved question could shadow its pitch to regulated issuers, while ADA keeps sliding.

The Motley Fool·2d ago
CME vs. Morningstar: Which Financial Stock Is a Better Buy for 2027?

CME Group dominates the global derivatives market with an exceptional net margin and a robust technology partnership with Alphabet. Morningstar leverages deep brand authority and a highly diversified customer base to drive consistent growth in investment data and research.

Filtered for CME Group Inc.More Headlines
04

Compare before deciding

Benchmark CME against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for CME Group Inc. (CME)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CME logoCMECME Group Inc.Current
$311.56$112.03B25.397.06%63.92%16.24%3.5%
ICE logoICEIntercontinental Exchange, Inc.
$172.22$97.12B23.369.27%33.78%14.05%1.12%
CBOE logoCBOECboe Global Markets, Inc.
$370.07$38.73B26.1715.31%28.33%26.84%0.73%
NDAQ logoNDAQNasdaq, Inc.
$105.13$58.76B28.409.86%23.71%17.28%0.99%
MKTX logoMKTXMarketAxess Holdings Inc.
$165.30$5.82B19.973.85%33.87%23.82%1.89%
MSCI logoMSCIMSCI Inc.
$636.58$46.28B33.269.51%43.87%—1.13%

Compare CME vs Peers

CME Group Inc. (CME) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs ICE

Most directly comparable listed peer for CME.

Scale Benchmark

vs JPM

Larger-name benchmark to compare CME against a more recognizable public peer.

Peer Set

Compare Top 5

vs ICE, CBOE, NDAQ, MKTX

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CME SEC Filings & Documents

CME Group Inc. (CME) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Oct 21, 2026·SEC

Material company update

Sep 25, 2026·SEC

Material company update

Aug 11, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 27, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Oct 23, 2026·SEC

FY 2026

Jul 24, 2026·SEC

FY 2026

Apr 24, 2026·SEC

Get notified when CME posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CME Frequently Asked Questions

CME Group Inc. (CME) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
How fast is CME Group Inc. growing?

CME Group Inc. (CME) grew revenue by 10.6% over the trailing twelve months, compared with the twelve months before.

Is CME profitable?

Yes. CME Group Inc. (CME) earned $4.40B in net income over the trailing twelve months (a 63.9% net margin).

Dividend & Returns
Does CME pay dividends?

Yes. CME Group Inc. (CME) pays a dividend that yields 3.50% at the current price, a moderate yield.

What is CME's return on equity?

CME Group Inc. (CME) had a return on equity (ROE) of 16.2% over the trailing twelve months. That is above the market's typical 10-15%.

Industry Metrics
What is CME Group Inc.'s net interest margin?

CME Group Inc. (CME) has a net interest margin (NIM) of -0.1%. NIM has been under pressure due to interest rate environment.

What is CME Group Inc.'s efficiency ratio?

CME Group Inc. (CME) has an efficiency ratio of 21.7%. This is excellent, indicating strong cost control.

What if you invested $1,000 in CME back in 2000?

Total return calculator · dividends reinvested · 26+ years of data

See returns →